Fingerprint
Dive into the research topics of 'Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: Results of a multicenter phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: Results of a multicenter phase II trial
Shernan G. Holtan, Preston D. Steen, Nathan R. Foster, Charles Erlichman, Fabiola Medeiros, Matthew M. Ames, Stephanie L. Safgren, David L. Graham, Robert J. Behrens, Matthew P. Goetz
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations